This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5clm
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==1,4-Oxazine BACE1 inhibitors== | ==1,4-Oxazine BACE1 inhibitors== | ||
| - | <StructureSection load='5clm' size='340' side='right' caption='[[5clm]], [[Resolution|resolution]] 2.61Å' scene=''> | + | <StructureSection load='5clm' size='340' side='right'caption='[[5clm]], [[Resolution|resolution]] 2.61Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5clm]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CLM OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5clm]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CLM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5CLM FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=52K:N-{3-[(3R)-5-AMINO-3-METHYL-3,6-DIHYDRO-2H-1,4-OXAZIN-3-YL]PHENYL}-5-CHLOROPYRIDINE-2-CARBOXAMIDE'>52K</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=52K:N-{3-[(3R)-5-AMINO-3-METHYL-3,6-DIHYDRO-2H-1,4-OXAZIN-3-YL]PHENYL}-5-CHLOROPYRIDINE-2-CARBOXAMIDE'>52K</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5clm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5clm OCA], [https://pdbe.org/5clm PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5clm RCSB], [https://www.ebi.ac.uk/pdbsum/5clm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5clm ProSAT]</span></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/BACE1_HUMAN BACE1_HUMAN] Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase.<ref>PMID:10677483</ref> <ref>PMID:20354142</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 18: | Line 18: | ||
</div> | </div> | ||
<div class="pdbe-citations 5clm" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5clm" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Beta secretase 3D structures|Beta secretase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: Alexander | + | [[Category: Large Structures]] |
| - | [[Category: Alonso | + | [[Category: Alexander R]] |
| - | [[Category: | + | [[Category: Alonso De Diego S]] |
| - | [[Category: | + | [[Category: Alonso JM]] |
| - | [[Category: | + | [[Category: Austin N]] |
| - | [[Category: Cleyn | + | [[Category: Borghys H]] |
| - | [[Category: Delgado | + | [[Category: De Cleyn M]] |
| - | + | [[Category: Delgado O]] | |
| - | [[Category: Garcia-Molina | + | [[Category: Garcia-Molina A]] |
| - | [[Category: Gijsen | + | [[Category: Gijsen H]] |
| - | [[Category: | + | [[Category: MacDonald G]] |
| - | [[Category: Lamenca | + | [[Category: Martinez Lamenca C]] |
| - | + | [[Category: Moechars D]] | |
| - | [[Category: Moechars | + | [[Category: Oehlrich D]] |
| - | [[Category: Oehlrich | + | [[Category: Prokopcova H]] |
| - | [[Category: Prokopcova | + | [[Category: Rombouts F]] |
| - | [[Category: Rombouts | + | [[Category: Surkyn M]] |
| - | [[Category: Surkyn | + | [[Category: Trabanco A]] |
| - | [[Category: Trabanco | + | [[Category: Tresadern G]] |
| - | [[Category: Tresadern | + | [[Category: Van Brandt S]] |
| - | [[Category: | + | [[Category: Van Gool M]] |
| - | [[Category: | + | [[Category: Vos A]] |
| - | [[Category: | + | |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
1,4-Oxazine BACE1 inhibitors
| |||||||||||
Categories: Homo sapiens | Large Structures | Alexander R | Alonso De Diego S | Alonso JM | Austin N | Borghys H | De Cleyn M | Delgado O | Garcia-Molina A | Gijsen H | MacDonald G | Martinez Lamenca C | Moechars D | Oehlrich D | Prokopcova H | Rombouts F | Surkyn M | Trabanco A | Tresadern G | Van Brandt S | Van Gool M | Vos A
